Adverse effects associated with proton pump inhibitors

JAMA Internal Medicine

Volumn 176, Issue 2, 2016, Pages 172-174

  Schoenfeld, Adam Jacob ^a   Grady, Deborah ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

FEMALE; HUMAN; MALE; RENAL INSUFFICIENCY, CHRONIC;

FEMALE; HUMANS; MALE; PROTON PUMP INHIBITORS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84957947495     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.7927     Document Type: Editorial

References (13)

1. Grady D, Redberg RF. Less is more: how less health care can result in better health. Arch Intern Med. 2010;170(9):749-750.
2. Katz MH. Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users. Arch Intern Med. 2010;170(9): 747-748.
3. Lazarus B, Yuan C, Wilson FP, et al. Proton pump inhibitor use and the risk of chronic kidney disease [published online January 11, 2016]. JAMA Intern Med. doi:10.1001/jamainternmed.2015.7193.
4. Antoniou T, Macdonald EM, Hollands S, et al. Proton pump inhibitors and the risk of acute kidney injury in older patients: A population-based cohort study. CMAJ Open. 2015;3(2):E166-E171.
5. Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, et al. Proton pump inhibitors linked to hypomagnesemia: A systematic review and meta-Analysis of observational studies. Ren Fail. 2015;37(7):1237-1241.
6. Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-Analysis. Am J Gastroenterol. 2012;107(7):1011-1019.
7. Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS. Use of acid-suppressive drugs and risk of pneumonia: A systematic review and meta-Analysis. CMAJ. 2011;183(3):310-319.
8. Filion KB, Chateau D, Targownik LE, et al; CNODES Investigators. Proton pump inhibitors and the risk of hospitalisation for community-Acquired pneumonia: replicated cohort studies with meta-Analysis. Gut. 2014;63(4):552-558.
9. Zhou B, Huang Y, Li H, Sun W, Liu J. Proton-pump inhibitors and risk of fractures: An updatemeta-Analysis [published online October 13, 2015]. Osteoporos Int. doi:10.1007/s00198-015-3365-x.
10. Klepser DG, Collier DS, Cochran GL. Proton pump inhibitors and acute kidney injury: A nested case-control study. BMC Nephrol. 2013;14:150.
11. Proton Pump Inhibitors Information. 2015; http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm213259.htm. Accessed November 12, 2015.
12. Focks JJ, Brouwer MA, van Oijen MG, Lanas A, Bhatt DL, Verheugt FW. Concomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome: A systematic review. Heart. 2013;99(8):520-527.
13. Melloni C, Washam JB, JonesWS, et al. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review. Circ Cardiovasc Qual Outcomes. 2015;8(1):47-55.